Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Nov;82(2):257–261. doi: 10.1111/j.1365-2249.1990.tb05436.x

Increased production of the third component of complement (C3) by monocytes from patients with systemic lupus erythematosus.

H Tsukamoto 1, A Ueda 1, K Nagasawa 1, Y Tada 1, Y Niho 1
PMCID: PMC1535108  PMID: 2242606

Abstract

We measured in vitro C3 production by peripheral blood monocytes from patients with systemic lupus erythematosus (SLE), and found it to be significantly greater than that from normal controls. We also found that monocytes from SLE patients with active disease produced a markedly larger amount of C3 than those from SLE patients with inactive disease. Production of C3 by monocytes correlated with serum levels of anti-dsDNA antibodies and inversely correlated with serum C3 levels in SLE patients. Serial measurement of C3 in the culture supernatant from each SLE patient showed that C3 production by monocytes fell in parallel with a decrease of disease activity. The effect of corticosteroids was ruled out as there was no relation between the level of C3 production by monocytes and the dose of prednisolone. This seems to be the first study in which the C3 production was assayed at a cellular level in SLE patients, and this study suggests that the local C3 production is increased in SLE patients.

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Rosen F. S. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest. 1967 Dec;46(12):2021–2034. doi: 10.1172/JCI105691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alper C. A., Rosen F. S. Genetics of the complement system. Adv Hum Genet. 1976;7:141–188. doi: 10.1007/978-1-4757-0659-8_4. [DOI] [PubMed] [Google Scholar]
  3. Auerbach H. S., Baker R. D., Matthews W. J., Jr, Colten H. R. Molecular mechanism for feedback regulation of C4 biosynthesis in guinea pig peritoneal macrophage. J Exp Med. 1984 Jun 1;159(6):1750–1761. doi: 10.1084/jem.159.6.1750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Charlesworth J. A., Peake P. W., Golding J., Mackie J. D., Pussell B. A., Timmermans V., Wakefield D. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus. Ann Rheum Dis. 1989 Feb;48(2):153–159. doi: 10.1136/ard.48.2.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Colten H. R., Ooi Y. M., Edelson P. J. Synthesis and secretion of complement proteins by macrophages. Ann N Y Acad Sci. 1979;332:482–490. doi: 10.1111/j.1749-6632.1979.tb47142.x. [DOI] [PubMed] [Google Scholar]
  6. Einstein L. P., Hansen P. J., Ballow M., Davis A. E., 3rd, Davis J. S., 4th, Alper C. A., Rosen F. S., Colten H. R. Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans. J Clin Invest. 1977 Nov;60(5):963–969. doi: 10.1172/JCI108876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fauci A. S., Haynes B., Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med. 1978 Nov;89(5 Pt 1):660–676. doi: 10.7326/0003-4819-89-5-660. [DOI] [PubMed] [Google Scholar]
  8. Fearon D. T., Kaneko I., Thomson G. G. Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes. J Exp Med. 1981 Jun 1;153(6):1615–1628. doi: 10.1084/jem.153.6.1615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hopkins P., Belmont H. M., Buyon J., Philips M., Weissmann G., Abramson S. B. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthritis Rheum. 1988 May;31(5):632–641. doi: 10.1002/art.1780310508. [DOI] [PubMed] [Google Scholar]
  10. Katayama S., Chia D., Knutson D. W., Barnett E. V. Decreased Fc receptor avidity and degradative function of monocytes from patients with systemic lupus erythematosus. J Immunol. 1983 Jul;131(1):217–222. [PubMed] [Google Scholar]
  11. LANGE K., WASSERMAN E., SLOBODY L. B. The significance of serum complement levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus. Ann Intern Med. 1960 Oct;53:636–646. doi: 10.7326/0003-4819-53-4-636. [DOI] [PubMed] [Google Scholar]
  12. Linker-Israeli M., Bakke A. C., Kitridou R. C., Gendler S., Gillis S., Horwitz D. A. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol. 1983 Jun;130(6):2651–2655. [PubMed] [Google Scholar]
  13. Passwell J., Schreiner G. F., Nonaka M., Beuscher H. U., Colten H. R. Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. J Clin Invest. 1988 Nov;82(5):1676–1684. doi: 10.1172/JCI113780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Perlmutter D. H., Colten H. R. Molecular immunobiology of complement biosynthesis: a model of single-cell control of effector-inhibitor balance. Annu Rev Immunol. 1986;4:231–251. doi: 10.1146/annurev.iy.04.040186.001311. [DOI] [PubMed] [Google Scholar]
  15. Perlmutter D. H., Dinarello C. A., Punsal P. I., Colten H. R. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest. 1986 Nov;78(5):1349–1354. doi: 10.1172/JCI112721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Perlmutter D. H., Goldberger G., Dinarello C. A., Mizel S. B., Colten H. R. Regulation of class III major histocompatibility complex gene products by interleukin-1. Science. 1986 May 16;232(4752):850–852. doi: 10.1126/science.3010455. [DOI] [PubMed] [Google Scholar]
  17. Phillips R., Lomnitzer R., Wadee A. A., Rabson A. R. Defective monocyte function in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1985 Jan;34(1):69–76. doi: 10.1016/0090-1229(85)90008-x. [DOI] [PubMed] [Google Scholar]
  18. Schur P. H., Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968 Mar 7;278(10):533–538. doi: 10.1056/NEJM196803072781004. [DOI] [PubMed] [Google Scholar]
  19. Senger D. R., Hynes R. O. C3 component of complement secreted by established cell lines. Cell. 1978 Oct;15(2):375–384. doi: 10.1016/0092-8674(78)90006-5. [DOI] [PubMed] [Google Scholar]
  20. Shirakawa F., Yamashita U., Suzuki H. Decrease in HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE). J Immunol. 1985 Jun;134(6):3560–3562. [PubMed] [Google Scholar]
  21. Sliwinski A. J., Zvaifler N. J. Decreased synthesis of the third component of complement (C3) in hypocomplementemic systemic lupus erythematosus. Clin Exp Immunol. 1972 May;11(1):21–29. [PMC free article] [PubMed] [Google Scholar]
  22. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  23. Ueki A., Sai T., Oka H., Tabata M., Hosokawa K., Mochizuki Y. Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology. 1987 May;61(1):11–14. [PMC free article] [PubMed] [Google Scholar]
  24. Urowitz M. B., Gladman D. D., Tozman E. C., Goldsmith C. H. The lupus activity criteria count (LACC). J Rheumatol. 1984 Dec;11(6):783–787. [PubMed] [Google Scholar]
  25. de Ceulaer C., Papazoglou S., Whaley K. Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis. Immunology. 1980 Sep;41(1):37–43. [PMC free article] [PubMed] [Google Scholar]
  26. von Essen R., Isomäki H. Immunonephelometric quantitation of complement split product (C3d) plasma levels in rheumatic disease. Scand J Rheumatol. 1985;14(4):421–426. doi: 10.3109/03009748509102048. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES